HDACs as an emerging target in endocrine tumors: a comprehensive review-Reference-Cited by-同舟云学术

HDACs as an emerging target in endocrine tumors: a comprehensive review

Published:2023-03-04 Issue:2 Volume:18 Page:143-154
ISSN:1744-6651
Container-title:Expert Review of Endocrinology & Metabolism
language:en
Short-container-title:Expert Review of Endocrinology & Metabolism

Author:

Klieser Eckhard¹²,Neumayer Bettina¹²,Di Fazio Pietro³^ORCID,Mayr Christian⁴⁵,Neureiter Daniel¹²^ORCID,Kiesslich Tobias⁴⁵

Affiliation:

1. Institute of Pathology, Paracelsus Medical University/University Hospital Salzburg (SALK), Salzburg, Austria

2. Cancer Cluster Salzburg, Salzburg, Austria

3. Department of Visceral Thoracic and Vascular Surgery, Philipps University Marburg, Marburg, Germany

4. Center for Physiology, Pathophysiology and Biophysics, Institute of Physiology and Pathophysiology, Paracelsus Medical University, Salzburg, Austria

5. Department of Internal Medicine I, Paracelsus Medical University/University Hospital Salzburg (SALK), Salzburg, Austria

Funder

no funding

Publisher

Informa UK Limited

Subject

Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.1080/17446651.2023.2183840

Reference118 articles.

1. Histone acetylation in chromatin structure and transcription

2. Histone deacetylases and cancer

3. Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New insights into possible HDAC inhibitor resistance in DLBCL - Comment on 'defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cytotoxicity and overcome naïve resistance to pan-HDACi in diffuse large B cell lymphoma' by Havas et al.;Translational Oncology;2023-11